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Abstract Introduction Improvements in diagnosis and
treatment of cancer have increased cancer survival. This
study investigated the trends in return to work (RTW) after
cancer. Methods All employees absent from work due to
cancer diagnosed in 2002 (N = 1209), 2005 (N = 1522),
and 2008 (N = 1556) were selected from an occupational
health service register. Partial RTW was deﬁned as
resuming work with 50% of earnings and full RTW as
resuming work with 100% of earnings. The percentages of
partial and full RTW were determined 2 years after
reporting sick and compared with percentages of partial
and full RTW after cardiovascular disorders. The time to
partial and full RTW after cancer in 2005 and 2008 was
compared with the time to RTW in 2002. Results Partial
RTW decreased from 85% 2 years after cancer diagnosis in
2002 to 80% in 2005 and 69% in 2008. Full RTW
decreased from 80% 2 years after cancer diagnosis in 2002
to 74% in 2005 and 60% in 2008. RTW after cardiovas-
cular disorders showed similar changes. The time to partial
RTW in 2008 was longer than in 2002 after gastrointestinal
cancer and lung cancer. The time to full RTW in 2008 was
longer than in 2002 after breast cancer, gastrointestinal
cancer and lung cancer. Conclusions In the past decade, the
percentages of employees who resumed work after cancer
have decreased in The Netherlands, while the time to RTW
increased. Possible explanations include changes in dis-
ability policy, economic decline, and resulting decreases in
work latitude and workplace accommodations.
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Introduction
Cancer is a priority health issue in the European Union,
which was formalized in the European Partnership for
Action against Cancer launched in September 2009. This
partnership supports countries in their efforts to deal with
cancer by providing a framework for sharing information
and expertise in cancer prevention and treatment among a
wide range of stakeholders [1]. The annual incidence of
cancer has been estimated at 338 per 100,000 persons in
eastern European countries and 447 per 100,000 persons in
western European countries [2]. Cancer survival is highest
in the Scandinavian countries and lowest in the Czech
Republic, Poland, and Slovenia [3].
The age-adjusted 5-year survival for all cancers has
improved in Europe from 44% in 1989 to 50% in 1998. The
increase was almost linear up to 1994–1996 and then slo-
wed [4]. Major survival increases were found in patients
with prostate cancer, colorectal cancer, and breast cancer,
whereas survival increases were small for cancers of the
lung and cervix. The 5-year survival of women increased
from 52% in 1989 to 59% in 1998 and the 5-year survival
of men from 34 to 39% with a signiﬁcant trend heteroge-
neity between the sexes [4–6]. Survival trends were also
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greater increase in survival than older patients of both
sexes.
The increasing cancer survival means that more and
more individuals resume their everyday life, which also
includes remaining in or returning to work. Return to work
is frequently viewed as an indicator of recovery from
cancer [7]. Cancer survivors may try to re-establish their
former structure of everyday life and get back to work after
treatment, because they see this as a normal and healthy
existence [8]. In that case, it is likely that return to work
rates after cancer will have increased parallel to the
improved cancer survival. This assumption is supported by
studies of the employment status of cancer survivors
3–20 years after diagnosis. Studies performed between
1986 and 1999 reported that 62% (range 30–93%) of
cancer survivors was employed 3–20 years after diagnosis,
and studies performed between 2000 and 2006 found
71% (range 41–84%) of cancer survivors to be employed
[9–17]. However, comparison of employment statistics is
impeded by differences in social security systems across
countries and by both how and when (un)employment was
assessed. Moreover, the employment status 3–20 years
after cancer diagnosis reﬂects sustaining work rather than
resuming work after cancer.
The present study investigated return to work (RTW)
within 2 years of cancer diagnosis in 2002, 2005, and 2008
using sickness absence data recorded in an occupational
health service register. RTW after cancer was investigated
in two ways. First, the percentage of employees who
resumed work was measured 2 years after cancer diagno-
sis. To distinguish between cancer-speciﬁc trends and
national trends, the percentage of employees with RTW
after cancer was compared with the percentage of
employees with RTW after cardiovascular disorders in
2002, 2005, and 2008. Second, the time to RTW after
cancer in 2005 and in 2008 was compared with the time to
RTW after cancer in 2002.
Methods
Study Setting
In The Netherlands, employers report the dates on which
employees call in sick and the dates they resume work
partially or fully to an occupational health service for
recording purposes and as a request to start medical guid-
ance of the sick-listed employee. Sick-listed employees
visit the occupational physician (OP) usually in the third
week of absence from work for a medical certiﬁcation of
sickness absence. The OP records the diagnosis of the
sickness certiﬁcate in the sickness absence register using
the codes of the 10th version of the International Classiﬁ-
cation of Diseases (ICD-10), and evaluates recovery and
return to work activities every 4 to 6 weeks.
Ethical Considerations
Approval from a medical ethics board was not necessary
for this study, because the Act on Scientiﬁc Medical
Research does not apply to research on anonymized
records. Employees gave informed consent to the use their
sickness absence data for scientiﬁc analysis.
Study Population
Between 2002 and 2010, the sickness absence register of
365ArboNed contained the sickness absence data and med-
ical diagnoses of more than one million employees. The
employees worked in 33,000 companies of different eco-
nomic sectors representative of the Dutch workforce, except
for the primary sector (i.e., agriculture, forestry, ﬁshery, and
mining) which was under-represented in the register.
From the 365ArboNed Occupational Health Service
register, the sickness absence episodes certiﬁed by the OP
as being due to breast cancer (ICD-10 C50), genital cancer
(ICD-10 C51–C63), gastrointestinal cancer (ICD-10 C15–
C26), lung cancer (ICD-10 C30–C39), skin cancer (ICD-10
C43–C44), or blood malignancies (ICD-10 C81–C96) in
2002, 2005, and 2008 were selected.
For comparison, sickness absence episodes certiﬁed as
being due to cardiovascular disorders (ICD-10 I21, i.e.
acute myocardial infarction and ICD-10 I64, i.e. stroke not
speciﬁed as hemorrhage or infarction) in 2002, 2005, and
2008 were selected from the register. Cardiovascular dis-
orders were chosen as a reference, because, like most
cancers, cardiovascular disorders are more common in
older employees and the median duration of sickness
absence due to cardiovascular disorders (295 days) was
comparable with the mediation duration of sickness
absence due to cancer (309 days).
In this study, partial RTW was deﬁned as resuming work
with 50% of the earnings before sickness absence for at
least 28 consecutive days. Full RTW was deﬁned as
resuming work with 100% of the earnings before sickness
absence for at least 28 consecutive days. The follow-up
period for monitoring RTW was restricted to 2 years,
because the registration of sickness absence ended at the
moment employees were awarded a disability pension after
2 years of sickness absence.
Statistical Analysis
The percentages of employees with partial and full RTW
2 years after cancer diagnosis in 2002, 2005, and 2008 were
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123compared by v
2 analyses. A 1% signiﬁcance level was
chosen because of the number of v
2 tests performed for each
type of cancer. Interaction between diagnosis and year was
examined to reveal whether changes in the percentages of
RTW after cancer differed from cardiovascular disorders.
The time to RTW was determined by Cox proportional
hazards regression analysis for each type of cancer. The
Cox regression estimated hazard ratios (HR) and 99%
conﬁdence intervals (CI) of the time to partial and full
RTW in 2005 and 2008. A HR\1 reﬂects a longer time to
RTW and a HR[1 a shorter time to RTW compared to
2002. The hazard ratios were adjusted for age. The data of
patients who resigned, retired, or died within 2 years of
diagnosis were censored. All analyses were performed in
SPSS for Windows version 18.
Results
In 2002, 1209 employees (1.21%) reported sick because
they were diagnosed with cancer at a mean age of 47.5
(standard deviation (SD) = 9.2) years. In 2005, 1522
employees (1.52%) with a mean age of 47.8 (SD = 10.0)
years reported sick due to cancer and in 2008, 1556
employees (1.56%) with a mean age of 49.1 (SD = 9.8)
years. In the period from 2002 to 2008, the number of
episodes of sickness absence due to cancer increased,
especially among employees aged C50 years (Table 1).
Percentage of Employees with RTW
Overall, 85% of employees had partially resumed work
2 years after cancer diagnosed in 2002, 80% after cancer in
2005 and 69% after cancer in 2008 (Table 2). There was an
increase in the percentage of employees with partial RTW
after skin cancer from 87% in 2002 to 92% in 2008, but
this change was not signiﬁcant (p = 0.53). The percentage
of employees with partial RTW decreased signiﬁcantly for
most cancers, except blood malignancies, and in all age
categories. In comparison, the percentage of employees
with partial RTW after cardiovascular disorders decreased
from 89% in 2002 to 81% in 2008. There was no signiﬁcant
interaction between diagnosis and year (p = 0.51) indi-
cating that the decrease in partial RTW over time did not
differ between the diagnoses.
The percentages of employees with full RTW decreased
from 80% 2 years after cancer diagnosed in 2002 to 74%
after cancer in 2005 and 60% after cancer in 2008
(Table 2). The percentage of full RTW also decreased in
employees with cardiovascular disorders from 87% in 2002
to 75% in 2008. The decline in full RTW over time did not
differ signiﬁcantly between the diagnoses (p = 0.30). The
percentages of employees with full RTW after cancer
decreased in all age categories, whereas the percentage of
full RTW did not change signiﬁcantly after cardiovascular
disorders in employees\40 years of age.
Time to Partial and Full RTW
While the percentage of RTW indicates how many
employees had resumed work 2 years after cancer diag-
nosis, the time to RTW is a measure that reﬂects the
duration until RTW. The mean duration until partial RTW
Table 1 Numbers of employees absent from work due to cancer in
2002, 2005, and 2008
Total number of
employees in
the register
2002 2005 2008
N = 1,011,555 N = 1,010,686 N = 1,012,345
Breast cancer
Women 401 516 514
Men – – –
Genital cancer
Women 191 305 234
Men 95 130 164
Gastrointestinal cancer
Women 62 71 85
Men 162 162 212
Lung cancer
Women 44 56 67
Men 88 89 99
Skin cancer
Women 28 42 31
Men 51 55 66
Blood malignancies
Women 29 32 26
Men 58 64 58
All cancers
\40 years 260 (22%) 344 (23%) 274 (18%)
40–49 years 393 (33%) 447 (29%) 420 (27%)
C50 years 549 (45%) 728 (48%) 856 (55%)
Missing 2 3 6
Total cancer
cases
1209 (100%) 1522 (100%) 1556 (100%)
Reference
a
\40 years 82 (10%) 112 (11%) 89 (9%)
40–49 years 302 (36%) 320 (32%) 311 (32%)
C50 years 457 (54%) 562 (57%) 576 (59%)
Missing – 1 1
Total
reference
group
841 (100%) 995 (100%) 977 (100%)
a The reference group consisted of employees sick-listed with car-
diovascular disorders
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123was 264 (99% conﬁdence interval 249–279) days after
cancer diagnosis in 2002 and 297 (279–315) days in 2008.
The time to partial RTW after cancer in 2008 was longer
than the time to partial RTW after cancer in 2002, partic-
ularly after gastrointestinal cancer and lung cancer
(Table 3). The mean duration until full RTW was 318
(302–334) days after cancer diagnosis in 2002 and 343
(325–361) days in 2008. Again, the time to full RTW was
longer after cancer diagnosed in 2008 as compared to 2002,
especially for breast cancer, gastrointestinal cancer, and
lung cancer.
Discussion
This study investigated the trend in RTW within 2 years of
cancer diagnosis stratiﬁed by cancer site. The number of
employees who resumed work after cancer was lower in
2008 compared with 2002 as was reﬂected in a lower
percentage of RTW at 2 years after cancer diagnosis.
Similar trends were observed for RTW after cardiovascular
disorders. The age-adjusted hazard ratios indicated a longer
duration until both partial and full RTW after cancer in
2008 as compared with 2002.
Table 2 Percentage of employees resuming work within 2 years of diagnosis
2002 2005 2008 v
2 p-value
Partial
a (%) Full
b (%) Partial
a (%) Full
b (%) Partial
a (%) Full
b (%) Partial
a (%) Full
b (%)
Breast cancer 88 85 82 75 71 59 \0.01 \0.01
Genital cancer 94 91 91 88 85 79 0.01 \0.01
Gastrointestinal cancer 78 72 69 63 53 44 \0.01 \0.01
Lung cancer 65 61 52 47 41 33 \0.01 \0.01
Skin cancer 87 80 92 88 92 86 0.53 0.34
Blood malignancies 83 76 72 68 68 54 0.07 \0.01
All cancers
Total 85 80 80 74 69 60 \0.01 \0.01
\40 years 91 87 81 77 76 69 \0.01 \0.01
40-49 years 86 81 83 77 72 60 \0.01 \0.01
C50 years 81 77 77 71 65 57 \0.01 \0.01
Reference
c
Total 89 87 87 83 81 75 \0.01 \0.01
\40 years 89 87 85 78 78 78 0.12 0.23
40-49 years 91 89 90 86 80 76 \0.01 \0.01
C50 years 89 86 86 82 82 74 \0.01 \0.01
a Return to work with 50% or more of the earnings before sickness absence
b Return to work with equal earnings as before sickness absence
c The reference group consisted of employees sick-listed with cardiovascular disorders
Table 3 Age-adjusted time to return to work after cancer
Partial RTW
a Full RTW
b
2002 2005 2008 2002 2005 2008
Breast cancer 1.00 0.91 (0.76–1.10) 0.87 (0.72–1.06) 1.00 0.82 (0.67–0.99)** 0.70 (0.57–0.86)**
Genital cancer 1.00 1.07 (0.87–1.32) 1.06 (0.86–1.31) 1.00 1.03 (0.84–1.28) 1.01 (0.85–1.25)
Gastrointestinal cancer 1.00 0.82 (0.62–1.09) 0.66 (0.50–0.88)** 1.00 0.79 (0.59–1.07) 0.57 (0.42–0.77)**
Lung cancer 1.00 0.75 (0.50–1.13) 0.56 (0.37–0.85)** 1.00 0.67 (0.44–1.04) 0.46 (0.29–0.72)**
Skin cancer 1.00 1.25 (0.83–1.89) 1.29 (0.85–1.96) 1.00 1.37 (0.89–2.11) 1.25 (0.81–1.93)
Blood malignancies 1.00 0.73 (0.47–1.14) 0.75 (0.47–1.18) 1.00 0.79 (0.50–1.26) 0.64 (0.39–1.05)
Total 1.00 0.95 (0.85–1.06) 087 (0.78–0.98)** 1.00 0.91 (0.81–1.02) 0.76 (0.68–0.86)**
The table shows age-adjusted hazard ratios (99% conﬁdence intervals). A hazard ratio\1 reﬂects a longer time to RTW compared to 2002, and a
hazard ratio[1 reﬂects a shorter time compared to 2002; ** p\0.01
a Return to work with 50% or more of the earnings before sickness absence
b Return to work with equal earnings as before sickness absence
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The decline in the percentage of employees who returned
to work may be due to changes in the sickness absence
compensation policies. Before 2004, employers or
employers’ insurers compensated sickness absence for a
maximum period of 1 year, after which sick-listed
employees were assessed for a disability pension. If a
disability pension was awarded, employees were dis-
charged from their company and removed from the
sickness absence register. Thus, the employees who had
not resumed work within 1 year of reporting sick in 2002
were removed from the register. Since 2004, the
employer or employer’s insurer have to compensate and
register sickness absence for a period of 2 years. Hence,
the differences between the RTW percentages in 2002
and 2005 are likely to be due to differences in the period
during which sickness absence was compensated and
registered.
The sickness absence compensation policies did not
change between 2005 and 2008. Thus, the further
decrease in the percentages of partial and full RTW in
2008 compared with 2005 can not be attributed to chan-
ges in sickness absence policies or registration. Further-
more, a cancer-speciﬁc explanation is not likely as a
similar decline in RTW percentages was also found in
employees sick-listed with cardiovascular disorders. The
economic recession resulting from the ﬁnancial crisis in
2008 may explain why the RTW percentages were lower
in 2008 compared with 2005 as it has been reported that
sickness absence is related to the economic situation [18,
19]. However, Dutch sickness absence statistics show that
4.4% of the working days were lost due to sickness in
2005 compared with 4.3% of the working days in both
2008 and 2009 [20]. Although there was no increase in
sickness absence in the working population, unemploy-
ment has increased from 174,000 persons in 2008 to
220,000 persons in 2009 and an estimated 267,000 per-
sons in 2010 [20]. Therefore, another explanation for the
lower percentages of RTW within 2 years of reporting
sick in 2008 might be that employees were more often
discharged after long-term sickness absence in 2008. A
ﬁnal explanation for the lower percentage of RTW may
be that employees’ priorities in life have changed after
having experienced a life-threatening disease [10, 11].
Earlier studies have shown that employees put less value
on resuming work and may prefer having more leisure
time to spend with family and friends or enjoy hobbies
[7, 8, 21]. However, the sickness absence register pro-
vided no information on how employees valued returning
to work after cancer.
Time to Partial and Full RTW
The results of this study not only show lower percentages of
employees with partial or full RTW, but also a longer
duration until RTW after cancer in 2008 as compared with
2002, particularly for breast cancer, gastrointestinal cancer
and lung cancer. The longer time to RTW may be due to
changes in company sickness absence policies. In The
Netherlands, both employer and sick-listed employee are
responsible for occupational rehabilitation. From the start of
sickness absence, employers have to stay in contact with the
employee and, if possible, have to arrange modiﬁed work
duties or adjust work hours so that the sick-listed employee
remains in connection with the workplace. Perhaps, the
ﬁnancial crisis in 2008 made it less attractive for employers
to invest in work adjustments or in occupational rehabilita-
tion programs, which might have led to exclusion of long-
term sick-listed employees from the workplace. Further-
more, it was recognized that a supportive work environment
facilitatedRTWofcancersurvivors[9,15,22,23].Failureto
create a ‘welcome back’ work environment due to ﬁnancial
economic problems of companies might also explain the
longer time to RTW in 2008 compared with 2005.
Apart from policies and procedures, work-related factors
determine the work outcomes after cancer. The work envi-
ronment was already mentioned, but physical, cognitive, and
emotional work demands are also important [22]. From an
employee’s perspective, work is changing and becoming
moreandmorementallydemanding.Althoughthelevelofjob
control in The Netherlands is relatively high, annual surveys
of working conditions showed a steady increase in psycho-
social job demands [24]. For example, 24% of employees
experienced a high work pace and 33% a high work pressure
in 2005 compared with 34 and 41%, respectively, in 2008.
These increases in work pace and pressure may explain the
longer time to RTW in 2008 compared with 2005.
Alternatively, medical factors also explain the ﬁnding
that the time to RTW was longer after cancer diagnosis in
2008 compared with 2002. Breast cancer is one of the most
common cancers in individuals of working age. In The
Netherlands, the indication for chemotherapy was broad-
ened for young women with breast cancer in 2004 [25]. It
has been recognized that patients who received chemo-
therapy experienced more problems in resuming work and
returned to work later than those who were not treated with
chemotherapy [26–32].
Strengths and Limitations of the Study
A strength of the study was that it covered a large popu-
lation of more than one million employees representative
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123of the Dutch workforce. The registration of sickness
absence diagnoses did not change during the period of
study and there were no substantial changes in covered
industries over time. Furthermore, the outcome of partial
RTW next to full RTW provided good insight into
resuming work after cancer, even if employees decided to
work in lower earnings or lower-wage jobs for physical or
psychological reasons.
Although sickness absence register studies can be per-
formed rather inexpensively in large numbers of employ-
ees, the most important limitation is that the number of
variables available from the sickness absence register is
limited. The sickness absence register contained social
security numbers linking information on name, address,
age, gender, and company to the sickness absence dates
and diagnoses. Information on work conditions was avail-
able, but was not up to date though these factors are known
to play an important role in RTW after cancer [9–16, 22].
Additional medical information was not available from the
sickness absence register, while RTW after cancer depends
on the cancer stage, site, treatment, and comorbidity [9, 22,
23]. Another limitation was that information on actual job
demands, work accommodations to facilitate RTW after
cancer, and the willingness of employers to accommodate
an early RTW was lacking.
In conclusion, the RTW percentage after cancer has
decreased in The Netherlands, but a similar decline was
observed for RTW after cardiovascular disorders. Fur-
thermore, the time to RTW was longer after cancer diag-
nosis in 2008 as compared with 2002. RTW should be
monitored in different countries to reveal the trends in
RTW after cancer in other countries. Continued attention
for RTW after cancer is required, because the results of this
study showed an increasing incidence of cancer in the
working population, particularly among employees aged
C50 years. Hence, sickness absence and RTW of cancer
survivors is likely to be an increasing problem to be
addressed in the ageing working population.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
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